- Combretastatin A-4 phosphate
-
Combretastatin A-4 phosphate Systematic (IUPAC) name Phosphoric acid mono-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenyl} ester Clinical data Pregnancy cat. ? Legal status ? Identifiers ATC code ? PubChem CID 5351387 Synonyms CA4P
CA4PDChemical data Formula C18H21O8P Mol. mass 396.32 g/mol (exact mass : 396.097404) (what is this?) A-4 phosphate (verify) - For more information about this drug and its actions, see combretastatin.
Combretastatin A-4 phosphate (and its disodium salt) is a microtubule destabilizing drug, a type of vascular-targeting agent, a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis. It is a derivative of combretastatin.
Combretastatin A-4 phosphate is a prodrug. In vivo, it is dephosphorylated to its active metabolite, combretastatin A-4.[1]
References
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.